by John Conrad | May 14, 2024 | iBIO News
A new study tackles a burning question: how well do drugs discovered by artificial intelligence fare in clinical trials? With AI making waves in drug discovery, this question is becoming increasingly relevant. The challenge lies in defining what constitutes an...
by John Conrad | May 14, 2024 | Member News
AbbVie has entered into a licensing deal with Gilgamesh Pharmaceuticals to develop new treatments for psychiatric disorders. AbbVie will pay Gilgamesh an upfront payment of $65 million and up to $1.95 billion in potential milestones. Gilgamesh is developing drugs...
by John Conrad | May 13, 2024 | Policy News
U.S. legislation could disrupt drug supply chain This week’s Policy Highlight looks at the BIOSECURE Act, a bill currently being debated in Congress. The Act aims to limit collaboration between U.S. companies and certain Chinese firms in the biotechnology...
by John Conrad | May 13, 2024 | Member News
In a promising development for Alzheimer’s research, Takeda Pharmaceutical Company and AC Immune SA announced a collaboration to develop and commercialize a new treatment approach. The agreement focuses on ACI-24.060, an active immunotherapy candidate designed...
by John Conrad | May 9, 2024 | iBIO News
NewsBrief Weekly News Quiz: May 10 Did you read NewsBrief this week? We’ve put together a quick quiz based on the key topics from this week’s issue. Put your life sciences knowledge to the test and see how much you remember. Power Up Your Morning with iBIO...
by John Conrad | May 9, 2024 | iBIO News
I had the exciting opportunity to present at Project Medtech’s: Midwest Showcase hosted at mHUB. It was a fantastic event, and I wanted to share some key takeaways with you all, particularly regarding iBIO’s unwavering focus on fostering the medtech...
by John Conrad | May 7, 2024 | STEM Heros
by John Conrad | May 6, 2024 | Member News
Xeris announced a collaboration and licensing agreement with Beta Bionics. The agreement involves developing and commercializing a glucagon product using Xeris’ XeriSol™ technology for Beta Bionics’ proprietary bi-hormonal pump system for diabetes...
by John Conrad | May 3, 2024 | iBIO News
NewsBrief Weekly News Quiz: May 3 Did you read NewsBrief this week? We’ve put together a quick quiz based on the key topics from this week’s issue. Put your life sciences knowledge to the test and see how much you remember. Power Up Your Morning with iBIO...
by John Conrad | Apr 29, 2024 | Member News
Chicago’s reputation as a hub for innovation is gaining traction in the life sciences industry. A recent ranking placed Chicagoland in the top 10 metro centers for life sciences, and a key factor behind this recognition is the city’s impressive talent...
